Financials
Reported figures only · latest: Q4 2024
ILS · IFRS
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income7 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY24 | ILS 238.8M | −ILS 67.8M |
|---|
| FY23 | ILS 355.6M | −ILS 62M |
|---|
| FY22 | ILS 388.7M | ILS 44.8M |
|---|
| FY21 | ILS 219.7M | ILS 4.7M |
|---|
| FY20 | ILS 65M | −ILS 37.2M |
|---|
| FY19 | ILS 8.9M | −ILS 5.9M |
|---|
| FY18 | - | - |
|---|
MarginsShare of revenue- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|
| FY24 | 12.7% | −28.1% | −28.4% |
|---|
| FY23 | 29.6% | −11.7% | −17.4% |
|---|
| FY22 | 39.9% | 13% | 11.5% |
|---|
| FY21 | 41.5% | 12.8% | 2.1% |
|---|
| FY20 | 49.2% | −59% | −57.2% |
|---|
| FY19 | 16.6% | −38.3% | −66% |
|---|
| FY18 | - | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY24 | −ILS 71.3M |
|---|
| FY23 | −ILS 56.3M |
|---|
| FY22 | ILS 31.5M |
|---|
| FY21 | ILS 16.1M |
|---|
| FY20 | −ILS 12.9M |
|---|
| FY19 | −ILS 39.7M |
|---|
| FY18 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- Intercure Ltd.
- Healthcare median
Show the numbers
| Year | Intercure Ltd. | Healthcare median |
|---|
| FY24 | −28.4% | −47% |
|---|
| FY23 | −17.4% | −58% |
|---|
| FY22 | 11.5% | −80.4% |
|---|
| FY21 | 2.1% | −71.9% |
|---|
| FY20 | −57.2% | −62.2% |
|---|
| FY19 | −66% | −46.3% |
|---|
| FY18 | - | −49.6% |
|---|